NANOFORMULATION OF VITAMIN D DERIVATIVES AND/OR VITAMIN D METABOLITES
First Claim
1. A nanoformulation, comprising:
- nanoparticles, each nanoparticle comprising a modified chitosan polymer encapsulating at least one vitamin D derivative, at least one vitamin D metabolite, or combinations thereof,wherein the modified chitosan polymer comprises chitosan covalently linked to at least one entity selected from the group consisting of fatty acids, amino acids, deoxycholate, alginate, arginine-alginate, collagen, collagen-hydroxyapatite, poly(lactic-co-glycolic acid) (PLGA), and combinations thereof.
0 Assignments
0 Petitions
Accused Products
Abstract
A nanoformulation that includes loaded nanoparticles. Each nanoparticle includes a modified chitosan polymer encapsulating at least one vitamin D derivative, at least one vitamin D metabolite, or combinations thereof. The modified chitosan polymer includes chitosan covalently linked to at least one entity selected from the group consisting of fatty acids (omega-3-fattay acids), amino acids, deoxycholic acid, alginate, arginine-alginate, hyaluronic acid, collagen, collagen-hydroxyapatite, poly(lactic-co-glycolic acid) (PLGA), and combinations thereof. A structure includes a medium and the nanoformulation, wherein the nanoparticles are dispersed in the medium. A method of using the nanoformulation to treat a disorder and improve efficacy of current therapies where resistance develop in a patient includes administering to the patient a therapeutically effective amount of the nanoformulation for treating the disorder. A nano-cosmetic formulation, comprising a cosmetic includes the nanoformulation, wherein the modified chitosan polymer encapsulates the at least one vitamin D derivative, and wherein the at least one vitamin D derivative encompasses 0.1 to 20.0 wt % of the nano-cosmetic formulation'"'"'s total weight.
-
Citations
23 Claims
-
1. A nanoformulation, comprising:
-
nanoparticles, each nanoparticle comprising a modified chitosan polymer encapsulating at least one vitamin D derivative, at least one vitamin D metabolite, or combinations thereof, wherein the modified chitosan polymer comprises chitosan covalently linked to at least one entity selected from the group consisting of fatty acids, amino acids, deoxycholate, alginate, arginine-alginate, collagen, collagen-hydroxyapatite, poly(lactic-co-glycolic acid) (PLGA), and combinations thereof. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23)
-
Specification